Walsh, Jessica J. http://orcid.org/0000-0001-8466-8451
Christoffel, Daniel J. http://orcid.org/0000-0002-6303-5134
Malenka, Robert C. http://orcid.org/0000-0002-5428-5211
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH103949)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK115985)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA042012)
Article History
Received: 13 March 2022
Revised: 9 May 2022
Accepted: 17 May 2022
First Online: 14 June 2022
Competing interests
: RCM is on the scientific advisory board of MapLight Therapeutics, MindMed, Bright Minds Biosciences, AZ Therapies, and Cyclerion.